Archives of Critical Care Medicine

Published by: Kowsar

The Correlation Between the Plasma Level of Endothelin-1 and Pulmonary Artery Pressure in Patients on Hemodialysis Due to End-Stage Renal Disease

Sasan Tavana 1 , Hasan Argani 1 , Mohammad Khani 2 , Maryam Shariatmadari 1 and Ali Dabbagh 3 , *
Authors Information
1 Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Cardiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Critical Care Medicine: January 28, 2015, 1 (1); e520
  • Published Online: August 28, 2014
  • Article Type: Brief Report
  • Received: January 2, 2014
  • Revised: March 7, 2014
  • Accepted: June 3, 2014
  • DOI: 10.5812/accm.520

To Cite: Tavana S, Argani H, Khani M, Shariatmadari M, Dabbagh A. The Correlation Between the Plasma Level of Endothelin-1 and Pulmonary Artery Pressure in Patients on Hemodialysis Due to End-Stage Renal Disease , Arch Crit Care Med. 2015 ; 1(1):e520. doi: 10.5812/accm.520.

Copyright © 2015, Kowsar Corp.; Published by Kowsar.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Rosenblum WD. Pulmonary arterial hypertension: pathobiology, diagnosis, treatment, and emerging therapies. Cardiol Rev. 2010; 18(2): 58-63[DOI][PubMed]
  • 2. Abman SH. Pulmonary hypertension in children: a historical overview. Pediatr Crit Care Med. 2010; 11(2 Suppl)-9[DOI][PubMed]
  • 3. Oishi P, Datar SA, Fineman JR. Pediatric pulmonary arterial hypertension: current and emerging therapeutic options. Expert Opin Pharmacother. 2011; 12(12): 1845-64[DOI][PubMed]
  • 4. Ventetuolo CE, Kawut SM, Lederer DJ. Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis. Respiration. 2012; 84(4): 299-305[DOI][PubMed]
  • 5. Yu J, Taylor L, Wilson J, Comhair S, Erzurum S, Polgar P. Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension. J Cell Physiol. 2013; 228(2): 322-9[DOI][PubMed]
  • 6. Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, et al. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation. 2012; 126(8): 963-74[DOI][PubMed]
  • 7. Rich S. Right ventricular adaptation and maladaptation in chronic pulmonary arterial hypertension. Cardiol Clin. 2012; 30(2): 257-69[DOI][PubMed]
  • 8. Morin C, Fortin S, Rousseau E. Docosahexaenoic acid monoacylglyceride decreases endothelin-1 induced Ca(2+) sensitivity and proliferation in human pulmonary arteries. Am J Hypertens. 2012; 25(7): 756-63[DOI][PubMed]
  • 9. Huang H, Zhang P, Wang Z, Tang F, Jiang Z. Activation of endothelin-1 receptor signaling pathways is associated with neointima formation, neoangiogenesis and irreversible pulmonary artery hypertension in patients with congenital heart disease. Circ J. 2011; 75(6): 1463-71[PubMed]
  • 10. Shao D, Park JE, Wort SJ. The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension. Pharmacol Res. 2011; 63(6): 504-11[DOI][PubMed]
  • 11. Pan P, Zhang X, Qian H, Shi W, Wang J, Bo Y, et al. Effects of electro-acupuncture on endothelium-derived endothelin-1 and endothelial nitric oxide synthase of rats with hypoxia-induced pulmonary hypertension. Exp Biol Med (Maywood). 2010; 235(5): 642-8[DOI][PubMed]
  • 12. Hamidi SA, Lin RZ, Szema AM, Lyubsky S, Jiang YP, Said SI. VIP and endothelin receptor antagonist: an effective combination against experimental pulmonary arterial hypertension. Respir Res. 2011; 12: 141[DOI][PubMed]
  • 13. Channick RN, Sitbon O, Barst RJ, Manes A, Rubin LJ. Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol. 2004; 43(12 Suppl S): 62S-7S[DOI][PubMed]
  • 14. Dupuis J, Jasmin JF, Prie S, Cernacek P. Importance of local production of endothelin-1 and of the ET(B)Receptor in the regulation of pulmonary vascular tone. Pulm Pharmacol Ther. 2000; 13(3): 135-40[DOI][PubMed]
  • 15. Yuan P, Wu WH, Gao L, Zheng ZQ, Liu D, Mei HY, et al. Oestradiol ameliorates monocrotaline pulmonary hypertension via NO, prostacyclin and endothelin-1 pathways. Eur Respir J. 2013; 41(5): 1116-25[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments